Key findings

PAEP is a biomarker related to prognosis and immunity in bladder cancer

What is known and what is new?

To conclude, our study suggested that PAEP was associated with tumor immunity, and might be a biomarker associated with the diagnosis and prognosis of BLCA patients, and a potential target of BLCA immunotherapy.

What is the implication, and what should change now?

The results obtained at present are all from the public database, which are not verified at the cellular and molecular level in vitro. In vitro experiments will be carried out in the later stage to further understand its molecular mechanism.

• Report here about implications and actions needed.